Drug Approval | December 28, 2021
Sun Pharma receives DCGI approval for Molxvir in India
The product is expected to be available in a week’s time
The product is expected to be available in a week’s time
DCGI approved the drug based on the review of clinical data
Flattish volume growth and subdued new launches were key factors for last month
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving accessibility to quality cardiac and neurovascular care in tier 2 and tier 3 cities
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
Sputnik M is a new member of the Sputnik vaccines family
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
Subscribe To Our Newsletter & Stay Updated
